Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 29, 2011

Atlas Biolabs Will Provide Roche NimbleGen SeqCap EZ Enrichment in Germany

  • Atlas Biolabs qualified as the first certified service provider (CSP) for the Roche NimbleGen SeqCap EZ genomic enrichment technology in Germany after passing the company’s certification process. Atlas will process customer gDNA samples using the complete NimbleGen Sequence Capture Array and solution-based capture workflow. Enriched samples can then be analyzed on the long-read Roche GS FLX and GS Junior platforms as well as on short-read sequencing platforms.

    Roche NimbleGen recently launched an addition to the SeqCap EZ product portfolio with SeqCap EZ Choice Libraries for enrichment of custom regions of interest in a single test tube. SeqCap EZ Library is a solution-based capture method that enables enrichment of the whole exome or regions of interest in a single test tube. Atlas is the second genomic service provider to join the Roche NimbleGen CSP Program in Europe for SeqCap EZ Exome libraries.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »